The second-order effects that the COVID-19 pandemic has had on pediatric populations

Lael M Yonker1,2, David Dredge1,3, Alasdair Munro4,5

  • 1Harvard Medical School, Boston, MA, USA.

Insights

COVID-19 poses long-term health risks for children and adolescents beyond acute infection. This review explores post-acute effects like MIS-C, Long Covid, and neurological complications in pediatric populations.

Area of Science:

  • Pediatric Health
  • Infectious Diseases
  • Public Health

Background:

  • Long-term health consequences of SARS-CoV-2 (COVID-19) are recognized in adults but under-recognized in children and adolescents.
  • Pediatric populations face unique second-order post-acute effects from COVID-19.

Purpose of the Study:

  • To review the second-order post-acute effects of COVID-19 on pediatric populations.
  • To outline common scenarios encountered in pediatric clinical practice related to SARS-CoV-2 infection.

Main Methods:

  • Literature review and synthesis of current knowledge on post-acute COVID-19 effects in children.
  • Analysis of clinical scenarios including Multisystem Inflammatory Syndrome in Children (MIS-C), Long Covid, and neurological/autoimmune complications.

Main Results:

  • Common post-acute scenarios include MIS-C, Long Covid, neurological and autoimmune complications.
  • SARS-CoV-2 infection impacts pediatric health from biological, epidemiological, and public health perspectives.
  • Non-pharmacological interventions have associated epidemiological and public health consequences.

Conclusions:

  • SARS-CoV-2 has complex second-order effects on child health, necessitating multidisciplinary interventions.
  • Prioritizing funding for surveillance, prevention, and research into post-acute viral complications is crucial.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
253
Bullying02:04

Bullying

A modern form of aggression is bullying. As you learn in your study of child development, socializing and playing with other children is beneficial for children’s psychological development. However, as you may have experienced as a child, not all play behavior has positive outcomes. Some children are aggressive and want to play roughly. Other children are selfish and do not want to share toys. One form of negative social interactions among children that has become a national concern is...
8.8K